| Status: Superseded | ||
AWMSG ADVICE SUPERSEDED BY NICE GUIDANCE ISSUED OCTOBER 2019. Refer to TA610: Pentosan polysulfate sodium for treating bladder pain syndrome for full guidance on NICE recommendations, including any specific restrictions on the use of the technology. AWMSG documentation provided for reference only. |
||
|
||
Medicine details |
||
| Medicine name | pentosan polysulfate sodium (Elmiron®) | |
| Formulation | 100 mg hard capsule | |
| Reference number | 3478 | |
| Indication | Treatment of bladder pain syndrome characterised by either glomerulations or Hunner’s lesions in adults with moderate to severe pain, urgency and frequency of micturition |
|
| Company | bene-Arzneimittel | |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders | |
| Submission type | Non-submission | |
| Status | Superseded | |
| Date of issue | 27/10/2017 | |
| NICE guidance | TA610: Pentosan polysulfate sodium for treating bladder pain syndrome |
|